The ADA Standards of Care recommends prescribing glucagon for all individuals at increased risk of level 2 (moderate) hypoglycemia so it’s available if needed.1
Patient has tried correcting hypoglycemia sugar (or drinks that are high in sugar) and has not improved
Patient is unable to safely swallow sugar or sugar-sweetened products to correct hypoglycemia
Patient feels like they might pass out
Patient experiences loss of consciousness or a seizure
Those around patients should be shown how to use Gvoke before an emergency happens. They may need to administer it if the patient has a severe low blood sugar event.
The ADA recommends glucagon be used in people unable or unwilling to eat.1
References: 1. American Diabetes Association. Glycemic targets: Standards of medical care in diabetes—2019. Diabetes Care. 2019;42(suppl 1):S61-S70. 2. National Institute of Diabetes and Digestive and Kidney Diseases. Hypoglycemia. https://www.niddk.nih.gov/-/media/Files/Diabetes/hypoglycemia_508.pdf. Published October 2008. Accessed June 4, 2019. Published August 2016. Accessed May 28, 2019. 3. Kedia N. Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach. Diabetes Metab Syndr Obes. 2011;4:337-346. 4. Geller AI, Shehab N, Lovegrove MC, et al. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Intern Med. 2014;174(5):678-686. 5. Gvoke Pre-Filled Syringe [instructions for use]. Chicago, IL: Xeris Pharmaceuticals, Inc. 6. Gvoke HypoPen [instructions for use]. Chicago, IL: Xeris Pharmaceuticals, Inc; 2020. 7. Gvoke [prescribing information], Chicago, IL; Xeris Pharmaceuticals, Inc.